“香港 HPV 疫苗第一股” 瑞科生物首日上市逆势收涨 1.81%

Gelonghui
2022.03.31 08:24
大市整体下跌之际，瑞科生物 (2179.HK) 今日首日上市逆势收涨 1.81% 报 25.25 港元，市值 121 亿港元。此次 IPO，扬子江药业集团、嘉实国际和红杉中国作为公司的基石投资人，基石认购比例超过 50%。此前，公司曾获君联资本、LYFE Capital、东方富海、沃盈资本、红杉中国、清池资本、淡马锡等众多知名投资机构的青睐。此次成功在港上市，成为 “香港 HPV 疫苗第一股”、“香港新型佐剂疫苗第一股”。
Source: Gelonghui The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.